Arginyl-Glutamine

• Description :

  Arginyl-Glutamine is a dipeptide that can decrease VEGF levels and inhibit retinal neovascularization in a mouse model of oxygen-induced retinopathy[1].

• Product Name Alternative :

  H-Arg-Gln-OH

• UNSPSC :

  12352209

• Target :

  VEGFR

• Type :

  Peptides

• Related Pathways :

  Protein Tyrosine Kinase/RTK

• Applications :

  Neuroscience-Neuromodulation

• Field of Research :

  Cardiovascular Disease

• Assay Protocol :

  https://www.medchemexpress.com/arginyl-glutamine.html

• Solubility :

  10 mM in DMSO

• Smiles :

  N=C(N)NCCC[C@H](N)C(N[C@H](C(O)=O)CCC(N)=O)=O

• Molecular Formula :

  C11H22N6O4

• Molecular Weight :

  302.33

• References & Citations :

  [1]Neu J, et al. The dipeptide Arg-Gln inhibits retinal neovascularization in the mouse model of oxygen-induced retinopathy. Invest Ophthalmol Vis Sci. 2006 Jul;47 (7) :3151-5.

• Shipping Conditions :

  Room temperature

• Scientific Category :

  Peptides

• Clinical Information :

  No Development Reported

• CAS Number :

  [2483-17-2]